Surfing the MASH Tsunami
Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL
- Update frequency
- every day
- Average duration
- 26 minutes
- Episodes
- 1069
- Years Active
- 2020 - 2025
S6 - E3 - Drugs and Diagnostics Evolve as the FDA Devolves
00:00:00 - Surf's Up: Season 6 Episode 3
Surfing the MASH Tsunami continues its coverage of the AASLD Emerging Trends Conference on MASLD, MetALD and ALD. This week, the panelists focus …
S6 - E2 - MetALD Epidemiology, MASLD Mortality and a PCP "Unicorn"
00:00:00 - Surf's Up: Season 6 Episode 2
Surfing the MASH Tsunami continues its coverage of the AASLD Emerging Trends Conference on MASLD, MetALD and ALD. This week, the panelists focus …
S6 - E1: Two Multispecialty February Conferences and Europe Prepares for Resmetirom
00:00:00 - Surf's Up! Season 6 Episode 1
SurfingMASH kicks off our sixth season in our new format, with three major elements to each episode. This week's Roundtable and Newsmakers segmen…
S5 - E26.5 - Looking Back at #TLM2024 - Promoting Healthy Livers and Looking Ahead to 2025
In this episode, Naim Alkhouri, Mike Betel, Michelle Long and Jeff McIntyre join Jörn Schattenberg and Roger Green to look back at The Liver Meeting 2024. This conversation reviews two …
S5 - E26.4 - Looking Back at #TLM2024 - Patient Advocacy and Patient-Centric Trials
In this episode, Naim Alkhouri, Mike Betel, Michelle Long and Jeff McIntyre join Jörn Schattenberg and Roger Green to look back at The Liver Meeting 2024. This conversation considers th…
S5 - E26.2 - Looking Back at #TLM2024 - Patient Genotyping and MASH Clusters
In this episode, Naim Alkhouri, Mike Betel, Michelle Long and Jeff McIntyre join Jörn Schattenberg and Roger Green to look back at The Liver Meeting 2024. This conversation considers ho…
S5 - E26.3 - Looking Back at #TLM2024 - FGF-21 Agents and the FDA Corner
In this episode, Naim Alkhouri, Mike Betel, Michelle Long and Jeff McIntyre join Jörn Schattenberg and Roger Green to look back at The Liver Meeting 2024. This conversation reviews the …
S5 - E26.1 - Looking Back at #TLM2024 - Semaglutide Passes the ESSENCE Test
In this episode, Naim Alkhouri, Mike Betel, Michelle Long and Jeff McIntyre join Jörn Schattenberg and Roger Green to look back at The Liver Meeting 2024. This conversation reviews the …
S5-26 - One Month Later: Looking Back at MASLD/MASH Coverage From The Liver Meeting 2024
00:00:00 – Surf’s Up: Season 5 Episode 26 - Last month, close to 8,000 hepatology stakeholders convened in San Diego for The Liver Meeting 2024. Hepatology Key Opinion Leader Naim Alkho…
S5 - E25 - Reviewing Expert Recommendations on the Use of Resmetirom
00:00:00 - Surf's Up: Season 5 Episode 25
On July 20, Clinical Gastroenterology and Hepatology released the paper, Expert Panel Recommendations: Practical Clinical Applications for Init…
S4 - E24.5 - SurfingMASH Question of The Week: Keys to Improving Provider-Patient Communication
Two weeks ago, the SurfingMASH Question of the Week asked, "What structural or educational changes do you anticipate will significantly improve Provider-Patient communication? Will thes…
S5 - E24.4 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Implications for GLI
In the second half of Roger Green's interview with Global Liver Institute Vice President, Liver Programs Jeff McIntyre, Jeff discusses the implications of his key EASL Congress takeaway…
S5 - E24.3 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Takeaways
This conversation contains the first half of Roger Green's interview with Global Liver Institute Vice President, Liver Programs Jeff McIntyre, during which the two discuss what Jeff con…
S5 - E24.2 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Implications
In the second half of Roger Green's interview with PharmaNest Founder and CEO Mathieu Petitjean, Matt discusses the implications of his key EASL Congress takeaways for PharmaNest.
Matt…
S5 - E24.1 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Takeaways
This conversation contains the first half of Roger Green's interview with PharmaNest Founder and CEO Mathieu Petitjean. After Matt tells the audience a little about his background and P…
S5 - E24 - A view of MASLD: Looking back at EASL Congress from six weeks later
00:00:00 - Surf's Up: Season 5 Episode 24
This week's episode on MASLD lessons from the EASL Congress 2024 includes three separate elements: individual interviews with PharmaNext Founde…
S5 SPECIAL 5 - Reviewing EASL Congress: Louise Campbell 3 (first-time material)
This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with SurfingMASH co-host and Tawazun Health Founder…
S5 SPECIAL 4 - Reviewing EASL Congress: Sven Francque
This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with Hepatology Key Opinion Leader and EASL Educati…
S5 SPECIAL 3 - Reviewing EASL Congress: Louise Campbell 2
This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with SurfingMASH co-host and Tawazun Health Founder…
S5 SPECIAL 2 - Reviewing EASL Congress: Louise Campbell I
This week, Surfing the MASH Tsunami looks back on interviews Roger Green conducted during the EASL Congress itself. This conversation with SurfingMASH co-host and Tawazun Health Founder…